CIK 0001427570
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Vyome Holdings, Inc
Sign in to watch- Ticker
- HIND
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 949-429-6680
- Business address
- 1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
- Former names
- ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 1 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-06 | SHACKNAI JONAH Director | Grant or award · Stock Option (Right to Buy) | +36,554 | 36,554 | ||
| 2017-06-06 | Kamdar Kim P. Director | Grant or award · Stock Option (Right to Buy) | +36,554 | 36,554 | ||
| 2017-06-06 | Stevenson Sharon Director | Grant or award · Stock Option (Right to Buy) | +36,554 | 36,554 | ||
| 2017-06-06 | HOWE LESLEY H Director | Grant or award · Stock Option (Right to Buy) | +36,554 | 36,554 | ||
| 2017-06-06 | Fisher Douglas Director | Grant or award · Stock Option (Right to Buy) | +36,554 | 36,554 | ||
| 2017-06-06 | MOATAZEDI DAVID Director | Grant or award · Stock Option (Right to Buy) | +36,554 | 36,554 | ||
| 2017-06-06 | DITTAMORE RAYMOND V Director | Grant or award · Stock Option (Right to Buy) | +36,554 | 36,554 | ||
| 2017-05-09 | Kamdar Kim P. Director | Grant or award · Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2017-05-09 | DITTAMORE RAYMOND V Director | Grant or award · Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2017-05-09 | Fisher Douglas Director | Grant or award · Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2017-05-09 | HOWE LESLEY H Director | Grant or award · Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2017-05-09 | Stevenson Sharon Director | Grant or award · Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2017-04-30 | Young Donald R VP of Quality Assurance | Grant or award | +1,868 | $9.03 | $17K | 1,868 |
| 2017-04-30 | Brister Mark VP of Research and Development | Grant or award | +1,550 | $9.03 | $14K | 162,010 |
| 2017-04-30 | Johnson Steven Ernest VP of Operations | Grant or award | +747 | $9.03 | $7K | 747 |
| 2017-04-30 | Drake Neil Director | Grant or award | +1,661 | $9.03 | $15K | 6,181 |
| 2017-04-30 | Rasdal Andrew P President & CEO | Grant or award | +2,768 | $9.03 | $25K | 453,263 |
| 2017-04-30 | Morisey Erin VP Strategic Partnerships | Grant or award | +1,785 | $9.03 | $16K | 1,785 |
| 2017-03-13 | MOATAZEDI DAVID Director | Grant or award · Stock Option (Right to Buy) | +59,988 | 59,988 | ||
| 2017-01-12 | SHACKNAI JONAH Director | Grant or award · Stock Option (right to buy) | +105,128 | 105,128 |
Page 14 of 17 · 322 trades